Company / Tangible Book Value per Share
Kymera Therapeutics, Inc. Tangible Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$24.34
FY2025
5-year range
-$1.67 / $24.34
FY2021-FY2025
Trend
+61.9%
vs FY2024
Sector context
#17 of 209
Health Care
What the data says
Among 209 Health Care companies, Kymera Therapeutics, Inc. is in the top 8% for tangible book value per share. Improved from $8.23 to $24.34 over the past 2 years.
Based on SEC 10-K filings.
24.34 in FY2025 with a 3-year CAGR of +36.8%. Top quartile in the Health Care sector.
Improved from $8.23 to $24.34 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +36.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 209This company $24.34 Sector average $119.74
▼
-79.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 61.9% year-over-year.
- Ranks #17 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.34 | +61.9% |
| FY2024 | $15.03 | +82.7% |
| FY2023 | $8.23 | -13.5% |
| FY2022 | $9.51 | +668.6% |
| FY2021 | -$1.67 | +90.6% |
| FY2020 | -$17.85 | +59.3% |
| FY2019 | -$43.81 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026